Semaglutide

Semaglutide

Nome del prodotto Semaglutide
Numero CAS 910463-68-2
Formula molecolare C187H291N45O59
Peso molecolare 4113.58
Aspetto Polvere di colore da bianco a bianco sporco
Purezza (HPLC) ≥98%
Confezione 5g, 10g, 50g per container

Hai bisogno di aiuto? Contatta il nostro team

Semaglutide Structure

Synonyms: Semaglutide, 910463-68-2, GLP-1 receptor agonist, GLP-1 analog, Semaglutide (USAN), Ozempic, Wegovy

Semaglutide is a synthetic analog of the human glucagon-like peptide-1 (GLP-1), a key incretin hormone that regulates glucose metabolism and appetite. It is a 31-amino acid peptide with a fatty acid side chain that enables extended half-life and once-weekly dosing. Developed for the treatment of type 2 diabetes and obesity, semaglutide has become a benchmark in the growing class of GLP-1 receptor agonists.

The molecule was engineered by substituting specific amino acids and attaching a C18 fatty diacid via a hydrophilic spacer, which promotes strong binding to albumin and slows renal clearance. This structural design allows for maintaining therapeutic concentrations over a week, a significant improvement over earlier GLP-1 analogs that required daily injections. Semaglutide is also being investigated for cardiovascular benefits and non-alcoholic steatohepatitis (NASH), reflecting its expanding clinical relevance.

As a research-grade peptide, semaglutide is supplied for laboratory use, including preclinical studies, analytical method development, and formulation research. It is typically offered as a lyophilized powder with a purity of at least 98% by HPLC, ensuring reliable performance in a range of experimental settings.

Funzione

  • GLP-1 receptor activation: Stimulates insulin secretion in a glucose-dependent manner.
  • Regolazione dell'appetito: Reduces food intake and promotes satiety.
  • Beta-cell protection: Supports pancreatic beta-cell function.
  • Cardiovascular benefits: May lower risk of major adverse cardiovascular events.

Fonte e standardizzazione

  • Fonte: Synthetic peptide, manufactured via solid-phase peptide synthesis.
  • Estrazione: Not applicable; produced by chemical synthesis.
  • Standardizzazione: Purity ≥98% by HPLC; identity confirmed by mass spectrometry.
  • Moduli: Lyophilized powder (as acetate or TFA salt).
  • Applicazioni: Research use only; not for human or veterinary use.

Caratteristiche tecniche

Parametro Specifiche
Analisi (HPLC) ≥98.0%
Aspetto Polvere di colore da bianco a bianco sporco
Water Content (KF) ≤8.0%
Acetate Content (if applicable) 5.0–12.0%
Endotoxin Level ≤5 EU/mg

Documentazione e forniture

  • Capacità mensile: 5 kg
  • Tempi di consegna: 5–10 working days after order confirmation
  • Documentazione: COA, SDS, TDS
  • Imballaggio: Double polyethylene bags inside aluminum foil bag; custom packaging available

Richiesta di preventivo

  • Il nostro indirizzo: 280 Main Street, Xian, Shaanxi, Cina
  • LyvBio S.r.l. — E-mail: info@lyvbio.com

RIMANI IN CONTATTO

Richiesta di preventivo

Il nostro indirizzo

Via Main 280, Xian, Shaanxi, Cina

×